FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2195261993> ?p ?o ?g. }

• W2195261993 endingPage "8" @default.
• W2195261993 startingPage "16140" @default.
• W2195261993 abstract "To determine if cetuximab combined with chemotherapy is beneficial for patients with advanced NSCLC after failure of first-line chemotherapy and EGFR-tyrosine kinase inhibitors (TKI). Twenty patients were treated with cetuximab in combination with pemetrexed, and 14 patients were treated with cetuximab in combination with docetaxel. Short-term response rates and long-term survival after salvage therapy were evaluated. Partial response (PR) occurred in 4 patients, stable disease (SD) occurred in 13 patients, and progressive disease (PD) occurred in 17 patients. No patient achieved a complete response (CR). The objective response rate (ORR) was 11.8% (4/34) and the disease control rate (DCR) was 50.0% (17/34). The disease progression rate (DPR) was 50% (17/34). Further analyses showed that the DCR was significantly higher in patients treated with EGFR-TKI for ≥6 months compared to patients treated with EGFR-TKI for <6 months (P=0.031). The median follow-up time was 5.5 months. The median progression-free survival (PFS) was 4.1 months. PFS was significantly longer in patients treated with EGFR-TKI for ≥ 6 months compared to those treated <6 months with EGFR-TKI (5.9 vs. 3.0 months; P=0.004). In general, however, patients tolerated this therapy well and there were no therapy-related deaths. As a salvage therapy, cetuximab combined with chemotherapy is indeed beneficial for patients with advanced NSCLC after first-line chemotherapy and subsequent EGFR-TKI treatment failure. In particular, this salvage regimen is beneficial for patients who were treated with EGFR-TKI for ≥6 months, and is well tolerated in these patients." @default.
• W2195261993 created "2016-06-24" @default.
• W2195261993 creator A5041897401 @default.
• W2195261993 creator A5052274720 @default.
• W2195261993 creator A5052298016 @default.
• W2195261993 creator A5053736386 @default.
• W2195261993 date "2015-01-01" @default.
• W2195261993 modified "2023-10-18" @default.
• W2195261993 title "Cetuximab combined with chemotherapy is beneficial for patients with advanced non-small cell lung cancer after EGFR-tyrosine kinase inhibitors failure." @default.
• W2195261993 cites W1882728012 @default.
• W2195261993 cites W1963969809 @default.
• W2195261993 cites W1968656389 @default.
• W2195261993 cites W1977292038 @default.
• W2195261993 cites W1977616377 @default.
• W2195261993 cites W1980278982 @default.
• W2195261993 cites W1994271665 @default.
• W2195261993 cites W1998905809 @default.
• W2195261993 cites W1999908952 @default.
• W2195261993 cites W2004818337 @default.
• W2195261993 cites W2011450183 @default.
• W2195261993 cites W2013113867 @default.
• W2195261993 cites W2016661084 @default.
• W2195261993 cites W2019792640 @default.
• W2195261993 cites W2028009636 @default.
• W2195261993 cites W2029633750 @default.
• W2195261993 cites W2036926586 @default.
• W2195261993 cites W2037602535 @default.
• W2195261993 cites W2044455399 @default.
• W2195261993 cites W2047665602 @default.
• W2195261993 cites W2050647940 @default.
• W2195261993 cites W2053029920 @default.
• W2195261993 cites W2054930937 @default.
• W2195261993 cites W2075062823 @default.
• W2195261993 cites W2076668534 @default.
• W2195261993 cites W2079652758 @default.
• W2195261993 cites W2098545015 @default.
• W2195261993 cites W2122553809 @default.
• W2195261993 cites W2123351515 @default.
• W2195261993 cites W2126228348 @default.
• W2195261993 cites W2133741785 @default.
• W2195261993 cites W2134667653 @default.
• W2195261993 cites W2139248078 @default.
• W2195261993 cites W2142459600 @default.
• W2195261993 cites W2143162846 @default.
• W2195261993 cites W2149649665 @default.
• W2195261993 cites W2149773490 @default.
• W2195261993 cites W2151175247 @default.
• W2195261993 cites W2151299797 @default.
• W2195261993 cites W2151881986 @default.
• W2195261993 cites W2186566624 @default.
• W2195261993 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4659016" @default.
• W2195261993 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26629127" @default.
• W2195261993 hasPublicationYear "2015" @default.
• W2195261993 type Work @default.
• W2195261993 sameAs 2195261993 @default.
• W2195261993 citedByCount "2" @default.
• W2195261993 countsByYear W21952619932017 @default.
• W2195261993 crossrefType "journal-article" @default.
• W2195261993 hasAuthorship W2195261993A5041897401 @default.
• W2195261993 hasAuthorship W2195261993A5052274720 @default.
• W2195261993 hasAuthorship W2195261993A5052298016 @default.
• W2195261993 hasAuthorship W2195261993A5053736386 @default.
• W2195261993 hasConcept C121608353 @default.
• W2195261993 hasConcept C126322002 @default.
• W2195261993 hasConcept C141071460 @default.
• W2195261993 hasConcept C143998085 @default.
• W2195261993 hasConcept C2776256026 @default.
• W2195261993 hasConcept C2776694085 @default.
• W2195261993 hasConcept C2777240266 @default.
• W2195261993 hasConcept C2778239845 @default.
• W2195261993 hasConcept C2778822529 @default.
• W2195261993 hasConcept C2779998722 @default.
• W2195261993 hasConcept C2780739268 @default.
• W2195261993 hasConcept C2780775027 @default.
• W2195261993 hasConcept C2781190966 @default.
• W2195261993 hasConcept C2781413609 @default.
• W2195261993 hasConcept C526805850 @default.
• W2195261993 hasConcept C71924100 @default.
• W2195261993 hasConceptScore W2195261993C121608353 @default.
• W2195261993 hasConceptScore W2195261993C126322002 @default.
• W2195261993 hasConceptScore W2195261993C141071460 @default.
• W2195261993 hasConceptScore W2195261993C143998085 @default.
• W2195261993 hasConceptScore W2195261993C2776256026 @default.
• W2195261993 hasConceptScore W2195261993C2776694085 @default.
• W2195261993 hasConceptScore W2195261993C2777240266 @default.
• W2195261993 hasConceptScore W2195261993C2778239845 @default.
• W2195261993 hasConceptScore W2195261993C2778822529 @default.
• W2195261993 hasConceptScore W2195261993C2779998722 @default.
• W2195261993 hasConceptScore W2195261993C2780739268 @default.
• W2195261993 hasConceptScore W2195261993C2780775027 @default.
• W2195261993 hasConceptScore W2195261993C2781190966 @default.
• W2195261993 hasConceptScore W2195261993C2781413609 @default.
• W2195261993 hasConceptScore W2195261993C526805850 @default.
• W2195261993 hasConceptScore W2195261993C71924100 @default.
• W2195261993 hasIssue "9" @default.
• W2195261993 hasLocation W21952619931 @default.
• W2195261993 hasOpenAccess W2195261993 @default.
• W2195261993 hasPrimaryLocation W21952619931 @default.

• next